Tillkännagivande • Jul 07
Extendicare Inc. to Report Q2, 2026 Results on Aug 06, 2026 Extendicare Inc. announced that they will report Q2, 2026 results After-Market on Aug 06, 2026 Tillkännagivande • Jun 15
Extendicare Inc. Declares Cash Dividend for the Month of June 2026, Payable on July 15, 2026 Extendicare Inc. announced that it has declared a cash dividend of CAD 0.0441 per common share of the Company for the month of June 2026, which is payable on July 15, 2026 to shareholders of record at the close of business on June 30, 2026. Tillkännagivande • May 09
Extendicare Inc. Declares Cash Dividend for the Month of May 2026, Payable on June 15, 2026 The Board of Directors of Extendicare declared a cash dividend of CAD 0.0441 per share for the month of May 2026, which is payable on June 15, 2026, to shareholders of record at the close of business on May 29, 2026. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada). Tillkännagivande • Apr 06
Extendicare Inc. to Report Q1, 2026 Results on May 07, 2026 Extendicare Inc. announced that they will report Q1, 2026 results After-Market on May 07, 2026 Tillkännagivande • Mar 19
Extendicare Inc. Announces Alan Torrie, Chair of the Board, and Donna Kingelin, Board Member, Will Not Stand for Re-Election Extendicare Inc. announced that current Board members Alan Torrie, Chair of the Board, and Donna Kingelin will not stand for re-election at the Meeting following over 10 years of service. Alan’s leadership and vision during his nine years as Chair enabled the transition of Extendicare from its real estate focus to a new business model focused on health services. Donna chaired the HR Committee and subsequently the Quality and Risk Committee during her tenure, building pivotal capabilities that are core to the Company’s health services mandate. Tillkännagivande • Feb 27
Extendicare Inc. Increases Cash Dividend for the Month of March 2026 Extendicare Inc. is increasing its monthly dividend by 5% to 4.41 cents per share, effective with the dividend to be declared in March 2026. Building on the 5% increase last year, the increase reflects the sustained operating performance throughout 2025 and sound capital structure. Continued strong performance would give the Company the opportunity to consider further dividend increases. Tillkännagivande • Feb 17
Extendicare Inc. Declares Cash Dividend for the Month of February 2026, Payable on March 16, 2026 Extendicare Inc. announced that it has declared a cash dividend of CAD 0.042 per common share of the Company for the month of February 2026, which is payable on March 16, 2026 to shareholders of record at the close of business on February 27, 2026. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada). Tillkännagivande • Jan 27
Extendicare Inc., Annual General Meeting, Apr 16, 2026 Extendicare Inc., Annual General Meeting, Apr 16, 2026. Tillkännagivande • Jan 16
Extendicare Inc. to Report Q4, 2025 Results on Feb 26, 2026 Extendicare Inc. announced that they will report Q4, 2025 results at 4:00 PM, US Eastern Standard Time on Feb 26, 2026 Tillkännagivande • Jan 15
Extendicare Inc. Declares Cash Dividend for the Month of January 2026, Payable on February 16, 2026 Extendicare Inc. announced that it has declared a cash dividend of CAD 0.042 per common share of the Company for the month of January 2026, which is payable on February 16, 2026 to shareholders of record at the close of business on January 30, 2026. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada). Tillkännagivande • Dec 13
Extendicare Inc. Declares Cash Dividend on Common Share for the Month of December 2025, Payable on January 15, 2026 Extendicare Inc. announced that it has declared a cash dividend of CAD 0.042 per common share of the Company for the month of December 2025, which is payable on January 15, 2026 to shareholders of record at the close of business on December 31, 2025. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada). Tillkännagivande • Nov 20
Extendicare Inc. (TSX:EXE) entered into a definitive agreement to acquire CBI Home Health from CBI Health Group Inc. for $570 million. Extendicare Inc. (TSX:EXE) entered into a definitive agreement to acquire CBI Home Health from CBI Health Group Inc. for $570 million on November 19, 2025. The transaction will be financed through cash on hand, proceeds from the Offering of $192 million and senior debt of $264.5 million.
For the period ending July 31, 2025, CBI Home Health reported total revenue of $478 million and EBITDA of $62 million.
The transaction is subject to customary closing conditions, including receipt of consents from third parties, including Ontario Health atHome and Assisted Living Alberta, and regulatory approval pursuant to the Competition Act. The transaction is expected to close in the first quarter of 2026. The transaction will be immediately accretive to earnings per share.
CIBC Capital Markets, Research Division acted as financial advisor for Extendicare Inc. Torys LLP acted as legal advisor for Extendicare Inc. Houlihan Lokey, Inc. acted as financial advisor for CBI Home Health. TD Securities, Inc. acted as financial advisor for CBI Home Health. Stikeman Elliott LLP acted as legal advisor for CBI Home Health. Tillkännagivande • Nov 13
Extendicare Inc. announces Monthly dividend, payable on December 15, 2025 Extendicare Inc. announced Monthly dividend of CAD 0.0420 per share payable on December 15, 2025, ex-date on November 28, 2025 and record date on November 28, 2025. Tillkännagivande • Oct 15
Extendicare Inc. Declares Cash Dividend on Common Share for the Month of October 2025, Payable on November 17, 2025 Extendicare Inc. announced that it has declared a cash dividend of CAD 0.042 per common share of the Company for the month of October 2025, which is payable on November 17, 2025 to shareholders of record at the close of business on October 31, 2025. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada). Tillkännagivande • Oct 07
Extendicare Inc. to Report Q3, 2025 Results on Nov 11, 2025 Extendicare Inc. announced that they will report Q3, 2025 results After-Market on Nov 11, 2025 Tillkännagivande • Sep 15
Extendicare Inc. Announces September 2025 Dividend, Payable on October 15, 2025 Extendicare Inc. announced that it has declared a cash dividend of CAD 0.042 per common share of the Company for the month of September 2025, which is payable on October 15, 2025 to shareholders of record at the close of business on September 30, 2025. Tillkännagivande • Aug 07
Extendicare Inc. Declares Cash Dividend for the Month of August 2025, Payable on September 15, 2025 The Board of Directors of Extendicare declared a cash dividend of $0.042 per share for the month of August 2025, which is payable on September 15, 2025, to shareholders of record at the close of business on August 29, 2025. Tillkännagivande • Jul 15
Extendicare Inc. Declares Cash Dividend for the Month of July 2025, Payable on August 15, 2025 Extendicare Inc. announced that it has declared a cash dividend of CAD 0.042 per common share of the Company for the month of July 2025, which is payable on August 15, 2025 to shareholders of record at the close of business on July 31, 2025. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada). Tillkännagivande • Jul 07
Extendicare Inc. to Report Q2, 2025 Results on Aug 06, 2025 Extendicare Inc. announced that they will report Q2, 2025 results After-Market on Aug 06, 2025 Tillkännagivande • Jun 18
Extendicare Inc. Declares Cash Dividend for the Month of June 2025, Payable on July 15, 2025 Extendicare Inc. announced that it has declared a cash dividend of CAD 0.042 per common share of the Company for the month of June 2025, which is payable on July 15, 2025 to shareholders of record at the close of business on June 30, 2025. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada). Tillkännagivande • Jun 03
Extendicare Inc. (TSX:EXE) completed the acquisition of Nine Long-Term Care Homes located Ontario and Manitoba from Revera Inc. Extendicare Inc. (TSX:EXE) has entered into an agreement to acquire Nine Long-Term Care Homes located Ontario and Manitoba from Revera Inc. for CAD 60.3 million on November 28, 2024. As for the consideration, it was approximately $60.3 million, consisting of $40.2 million in cash and the assumption of $20.1 million in certain liabilities, including government funding reimbursement obligations and committed capital maintenance project obligations, excluding transaction costs. The purchase price was funded from cash on hand.The purchase price is expected to be funded from cash on hand and existing senior secured credit facilities. Closing of the Transaction is subject to customary closing conditions, including receipt of regulatory approvals from the Ontario Ministry of Long-Term Care, Ontario Retirement Home Regulatory Authority, and Manitoba Health and Winnipeg Regional Health Authority, and is not conditional on financing or due diligence. The Transaction is expected to close in the second quarter. Torys LLP is acting as legal advisor to Extendicare in connection with the Transaction. Stormont Partners is acting as financial advisor to Revera and Goodmans LLP is acting as legal advisor to Revera in connection with the Transaction.
Extendicare Inc. (TSX:EXE) completed the acquisition of Nine Long-Term Care Homes located Ontario and Manitoba from Revera Inc. on June 1, 2025. Tillkännagivande • May 07
Extendicare Inc. Declares Cash Dividend for the Month of May 2025, Payable on June 16, 2025 The board of directors of Extendicare Inc. declared a cash dividend of CAD 0.042 per share for the month of May 2025, which is payable on June 16, 2025, to shareholders of record at the close of business on May 30, 2025. Tillkännagivande • Apr 16
Extendicare Inc Declares Cash Dividend for the Month of April 2025, Payable on May 15, 2025 Extendicare Inc. announced that it has declared a cash dividend of CAD 0.042 per common share of the Company for the month of April 2025, which is payable on May 15, 2025 to shareholders of record at the close of business on April 30, 2025. This dividend is designated as an "eligible dividend" within the meaning of the Income Tax Act (Canada). Tillkännagivande • Apr 03
Extendicare Inc. to Report Q1, 2025 Results on May 06, 2025 Extendicare Inc. announced that they will report Q1, 2025 results After-Market on May 06, 2025 Tillkännagivande • Mar 18
Extendicare Inc. Declares a Cash Dividend for the Month of March 2025, Payable on April 15, 2025 Extendicare Inc. announced that it has declared a cash dividend of CAD 0.042 per common share of the Company (the “Common Share”) for the month of March 2025, which is payable on April 15, 2025 to shareholders of record at the close of business on March 31, 2025. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada). Tillkännagivande • Mar 17
Extendicare Inc., Annual General Meeting, May 27, 2025 Extendicare Inc., Annual General Meeting, May 27, 2025. Location: ontario, toronto Canada Tillkännagivande • Feb 14
Extendicare Inc. Announces Cash Dividend for the Month of February 2025, Payable on March 17, 2025 Extendicare Inc. announced that it has declared a cash dividend of CAD 0.04 per common share of the Company for the month of February 2025, which is payable on March 17, 2025 to shareholders of record at the close of business on February 28, 2025. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada). Tillkännagivande • Jan 15
Extendicare Inc. Declares Cash Dividend for the Month of January 2025, Payable on February 14, 2025 Extendicare Inc. announced that it has declared a cash dividend of CAD 0.04 per common share of the company (the common share) for the month of January 2025, which is payable on February 14, 2025 to shareholders of record at the close of business on January 31, 2025. Tillkännagivande • Jan 13
Extendicare Inc. to Report Q4, 2024 Results on Feb 27, 2025 Extendicare Inc. announced that they will report Q4, 2024 results After-Market on Feb 27, 2025 Tillkännagivande • Dec 13
Extendicare Announces December 2024 Dividend, Payable on January 15, 2025 Extendicare Inc. announced that it has declared a cash dividend of CAD 0.04 per common share of the Company (the “Common Share”) for the month of December 2024, which is payable on January 15, 2025 to shareholders of record at the close of business on December 31, 2024. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada). Tillkännagivande • Nov 13
Extendicare Inc. Declares Cash Dividend, Payable on December 16, 2024 The Board of Directors of Extendicare Inc. declared a cash dividend of $0.04 per share for the month of November 2024, which is payable on December 16, 2024, to shareholders of record at the close of business on November 29, 2024. Tillkännagivande • Oct 15
Extendicare Inc. Declares Cash Dividend for the Month of October 2024, Payable on November 15, 2024 Extendicare Inc. announced that it has declared a cash dividend of CAD 0.04 per common share of the Company (the “Common Share”) for the month of October 2024, which is payable on November 15, 2024 to shareholders of record at the close of business on October 31, 2024. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada). Tillkännagivande • Oct 04
Extendicare Inc. to Report Q3, 2024 Results on Nov 12, 2024 Extendicare Inc. announced that they will report Q3, 2024 results After-Market on Nov 12, 2024 Tillkännagivande • Sep 16
Extendicare Inc. Announces Cash Dividend for the Month of September 2024, Payable on October 15, 2024 Extendicare Inc. announced that it has declared a cash dividend of CAD 0.04 per common share of the Company (the “Common Share”) for the month of September 2024, which is payable on October 15, 2024 to shareholders of record at the close of business on September 30, 2024. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada). Tillkännagivande • Jul 15
Extendicare Inc. Announces July 2024 Cash Dividend, Payable on August 15, 2024 Extendicare Inc. announced that it has declared a cash dividend of CAD 0.04 per common share of the Company for the month of July 2024, which is payable on August 15, 2024 to shareholders of record at the close of business on July 31, 2024. Tillkännagivande • Jul 06
Extendicare Inc. to Report Q2, 2024 Results on Aug 12, 2024 Extendicare Inc. announced that they will report Q2, 2024 results After-Market on Aug 12, 2024 Tillkännagivande • Jun 18
Extendicare Inc. Declares Cash Dividend for the Month of June 2024, Payable on July 15, 2024 Extendicare Inc. announced that it has declared a cash dividend of C$0.04 per common share of the Company (the “Common Share”) for the month of June 2024, which is payable on July 15, 2024 to shareholders of record at the close of business on June 28, 2024. Tillkännagivande • May 24
Extendicare Inc. Announces Alan Hibben Not Been Re-Elected as A Director Extendicare Inc. at the annual meeting of shareholders held on May 23, 2024 announced that Alan Hibben did not receive a majority of votes in favour at the Meeting and thus has not been re-elected as a director of Extendicare and resigned as such effective at the end of the Meeting. Tillkännagivande • May 17
Extendicare Inc. Declares Cash Dividend for the Month of May 2024, Payable on June 17, 2024 The Board of Directors of Extendicare declared a cash dividend of $0.04 per share for the month of May 2024, which is payable on June 17, 2024, to shareholders of record at the close of business on May 31, 2024. Tillkännagivande • Apr 21
Extendicare Inc., Annual General Meeting, May 23, 2024 Extendicare Inc., Annual General Meeting, May 23, 2024, at 10:30 Eastern Daylight. Location: TMX Market Centre, 120 Adelaide Street West, Toronto Ontario Canada Agenda: To consider to receive the consolidated financial statements of the Company for the year ended December 31, 2023 and the report of the auditors thereon; to appoint the auditors of the Company and authorize the directors to fix the auditors remuneration; to elect the directors of the Company; to approve an advisory (non-binding) resolution to accept the approach of the Company to executive compensation disclosed in the Information Circular; and to discuss other matters. Tillkännagivande • Apr 15
Extendicare Inc. Declares Cash Dividend for the Month of April 2024, Payable on May 15, 2024 Extendicare Inc. announced that it has declared a cash dividend of CAD 0.04 per common share of the Company (the “Common Share”) for the month of April 2024, which is payable on May 15, 2024 to shareholders of record at the close of business on April 30, 2024. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada). Tillkännagivande • Apr 05
Extendicare Inc. to Report Q1, 2024 Results on May 15, 2024 Extendicare Inc. announced that they will report Q1, 2024 results After-Market on May 15, 2024 Tillkännagivande • Mar 08
Extendicare Inc. Declares Cash Dividend for the Month of March 2024, Payable on April 15, 2024 The Board of Directors of Extendicare Inc. declared a cash dividend of CAD 0.04 per share for the month of March 2024, which is payable on April 15, 2024, to shareholders of record at the close of business on March 29, 2024. Tillkännagivande • Feb 16
Extendicare Inc. Declares Cash Dividend for the Month of February 2024, Payable on March 15, 2024 Extendicare Inc. announced that it has declared a cash dividend of CAD 0.04 per common share of the Company for the month of February 2024, which is payable on March 15, 2024 to shareholders of record at the close of business on February 29, 2024. This dividend is designated as an eligible dividend within the meaning of the Income Tax Act (Canada). Tillkännagivande • Jan 20
Extendicare Inc. to Report Q4, 2023 Results on Mar 07, 2024 Extendicare Inc. announced that they will report Q4, 2023 results on Mar 07, 2024 Tillkännagivande • Dec 16
Extendicare Inc. Declares Cash Dividend for the Month of December 2023, Payable on January 15, 2024 Extendicare Inc. announced that it has declared a cash dividend of CAD 0.04 per common share of the Company (the Common Share) for the month of December 2023, which is payable on January 15, 2024 to shareholders of record at the close of business on December 29, 2023. Tillkännagivande • Nov 11
Extendicare Inc. Declares Cash Dividend for the Month of November 2023, Payable on December 15, 2023 The Board of Directors of Extendicare declared a cash dividend of $0.04 per share for the month of November 2023, which is payable on December 15, 2023, to shareholders of record at the close of business on November 30, 2023. Tillkännagivande • Oct 17
Extendicare Inc. Declares Cash Dividend for the Month of October 2023, Payable on November 15, 2023 Extendicare Inc. announced that it has declared a cash dividend of CAD 0.04 per common share of the Company for the month of October 2023, which is payable on November 15, 2023 to shareholders of record at the close of business on October 31, 2023. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada). Tillkännagivande • Oct 07
Extendicare Inc. to Report Q3, 2023 Results on Nov 09, 2023 Extendicare Inc. announced that they will report Q3, 2023 results at 4:00 PM, US Eastern Standard Time on Nov 09, 2023 Tillkännagivande • Sep 16
Extendicare Inc. Announces Cash Dividend for the September 2023, Payable on October 16, 2023 Extendicare Inc. announced that it has declared a cash dividend of CAD 0.04 per common share of the Company for the month of September 2023, which is payable on October 16, 2023 to shareholders of record at the close of business on September 29, 2023. Tillkännagivande • Aug 11
Extendicare Inc. Declares Cash Dividend for the Month of August 2023, Payable on September 15, 2023 The Board of Directors of Extendicare declared a cash dividend of $0.04 per share for the month of August 2023, which is payable on September 15, 2023, to shareholders of record at the close of business on August 31, 2023. This dividend is designated as an eligible dividend within the meaning of the Income Tax Act (Canada). Tillkännagivande • Aug 03
Extendicare Inc. (TSX:EXE) completed the acquisition of a 15 percent stake in a Portfolio of 24 Long Term Care Homes from Revera Inc. and Axium Infrastructure Inc. Extendicare Inc. (TSX:EXE) entered into an agreement to acquire a 15 percent stake in a Portfolio of 24 Long Term Care Homes from Revera Inc. on March 1, 2022. Extendicare will acquire a 15% managed interest in 18 “class A” long-term care homes located in Ontario and six homes in Manitoba. The remaining 85% interest will continue to be owned by an affiliate of Axium. Relatedly, on closing of the Acquisition, Extendicare will enter into management contracts with Revera to manage all of Revera’s other long-term care homes, which comprise 31 “class C” homes located in Ontario and one personal care home located in Manitoba. Extendicare will also enter into development arrangement agreements with Revera in respect of the potential redevelopment of those managed “class C” homes in Ontario into new homes. The aggregate cash consideration for the Transactions is approximately CAD 36.0 million plus the assumption of approximately CAD 34.0 million in debt, subject to customary adjustments. Certain of the associated debt will be refinanced or repaid on or before closing, resulting in changes in the allocation between cash consideration and debt assumption. The purchase price is expected to be funded from cash on hand. Closing of the Axium Transaction is subject to customary closing conditions, including receipt of regulatory approvals from the Ontario Ministry of Long-Term Care, and is not conditional on financing or due diligence. As of May 4, 2023, the transaction is expected to close by the end of Q3 2023. BMO Capital Markets is acting as financial advisor to Extendicare and Simon Knowling, Graham Rawlinson, Susan Nickerson, Craig Maurice and Nina Mansoori of Torys LLP is acting as legal advisor to Extendicare in connection with the Transactions. Stikeman Elliott LLP is acting as legal advisor to Axium in connection with the Transactions. Stormont Partners Advisory is acting as financial advisor to Revera and Goodmans LLP is acting as legal advisor to Revera in connection with the Revera Transactions.Extendicare Inc. (TSX:EXE) completed the acquisition of a 15 percent stake in a Portfolio of 24 Long Term Care Homes from Revera Inc. and Axium Infrastructure Inc. on August 1, 2022. Tillkännagivande • Jul 18
Extendicare Inc. Declares Cash Dividend for the Month of July 2023, Payable on August 15, 2023 Extendicare Inc. announced that it has declared a cash dividend of CAD 0.04 per common share of the Company (the “Common Share”) for the month of July 2023, which is payable on August 15, 2023 to shareholders of record at the close of business on July 31, 2023. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada). Tillkännagivande • Jul 07
Extendicare Inc. to Report Q2, 2023 Results on Aug 10, 2023 Extendicare Inc. announced that they will report Q2, 2023 results After-Market on Aug 10, 2023 Tillkännagivande • Jun 16
Extendicare Inc. Declares Cash Dividend for the Month of June 2023, Payable on July 17, 2023 Extendicare Inc. announced that it has declared a cash dividend of CAD 0.04 per common share of the company (The Common Share) for the month of June 2023, which Is Payable on July 17, 2023 to shareholders of record At the close of business on June 30, 2023. Tillkännagivande • Feb 16
Extendicare Inc. Declares Dividend for the Month of February 2023, Payable on March 15, 2023 Extendicare Inc. announced that it has declared a cash dividend of CAD 0.04 per common share of the company for the month of February 2023, which is payable on March 15, 2023 to shareholders of record at the close of business on February 28, 2023. Tillkännagivande • Jan 20
Extendicare Inc. to Report Q4, 2022 Results on Mar 02, 2023 Extendicare Inc. announced that they will report Q4, 2022 results After-Market on Mar 02, 2023 Tillkännagivande • Jan 17
Extendicare Inc. Declares Cash Dividend for the Month of January 2023, Payable on February 15, 2023 Extendicare Inc. announced that it has declared a cash dividend of CAD 0.04 per common share of the Company for the month of January 2023, which is payable on February 15, 2023 to shareholders of record at the close of business on January 31, 2023. This dividend is designated as an "eligible dividend" within the meaning of the Income Tax Act (Canada). Tillkännagivande • May 13
Extendicare Inc. Announces Dividend for the Month of May 2021, Payable on June 15, 2021 The Board of Directors of Extendicare Inc. declared a cash dividend of $0.04 per share for the month of May 2021, which is payable on June 15, 2021, to shareholders of record at the close of business on May 31, 2021. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada). Tillkännagivande • Mar 16
Extendicare Inc. Declares A Cash Dividend, Payable on April 15, 2021 Extendicare Inc. announced that it has declared a cash dividend of CAD 0.04 per common share of the company for the month of March 2021, which is payable on April 15, 2021 to shareholders of record at the close of business on March 31, 2021. This dividend is designated as an 'eligible dividend' within the meaning of the Income Tax Act (Canada). Tillkännagivande • Mar 13
Extendicare Inc., Annual General Meeting, May 27, 2021 Extendicare Inc., Annual General Meeting, May 27, 2021. Tillkännagivande • Jan 26
Extendicare Inc. to Report Q4, 2020 Results on Feb 24, 2021 Extendicare Inc. announced that they will report Q4, 2020 results After-Market on Feb 24, 2021 Tillkännagivande • Nov 13
Extendicare Inc. Appoints Matthew Morgan as Chief Medical Officer Extendicare Inc. announced that, Dr. Matthew Morgan joined company in the newly-created role of Chief Medical Officer on October 19, 2020. His focus is on developing and coordinating the implementation of clinical strategies that result in better outcomes for residents, clients and their families. Dr. Morgan is a practicing General Internal Medicine physician with a Masters in Clinical Epidemiology, and an Assistant Professor in the Faculty of Medicine at the University of Toronto. Tillkännagivande • Oct 10
Extendicare Inc. to Report Q3, 2020 Results on Nov 12, 2020 Extendicare Inc. announced that they will report Q3, 2020 results at 5:00 PM, Eastern Standard Time on Nov 12, 2020 Tillkännagivande • Jul 17
Extendicare Inc. to Report Q2, 2020 Results on Aug 13, 2020 Extendicare Inc. announced that they will report Q2, 2020 results at 5:00 PM, Eastern Standard Time on Aug 13, 2020 
